David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$708M |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$614M |
| 3 |
Merck
MRK
|
+$521M |
| 4 |
Bank of America
BAC
|
+$492M |
| 5 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$646M |
| 2 |
Tesla
TSLA
|
+$607M |
| 3 |
Microsoft
MSFT
|
+$491M |
| 4 |
Accenture
ACN
|
+$482M |
| 5 |
Broadcom
AVGO
|
+$438M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.84% |
| 2 | Consumer Discretionary | 9.28% |
| 3 | Healthcare | 6.84% |
| 4 | Financials | 6.63% |
| 5 | Industrials | 5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
PUT
TKO Group
TKO
$14.1B
| $10.4M | 0.01% |
84,000
| – | – |
|
1302
Anterix
ATEX
$1.81B
| $10.4M | 0.01% |
275,856
+197,970
| +254% | +$7.63M |
|
|
YMAB
1303
DELISTED
Y-mAbs Therapeutics
YMAB
| $10.4M | 0.01% |
787,536
-138,921
| -15% | -$1.76M |
|
|
USAR
1304
USA Rare Earth Inc
USAR
$4.75B
| $10.4M | 0.01% |
963,823
+200,000
| +26% | +$2.13M |
|
1305
CALL
Nutanix
NTNX
$18B
| $10.3M | 0.01% |
174,400
+8,800
| +5% | +$483K |
|
1306
Collegium Pharmaceutical
COLL
$852M
| $10.3M | 0.01% |
265,602
+66,739
| +34% | +$2.38M |
|
1307
Upbound Group
UPBD
$1.13B
| $10.2M | 0.01% |
319,830
+185,915
| +139% | +$5.98M |
|
|
NVO
1308
PUT
Novo Nordisk
NVO
$215B
| $10.2M | 0.01% |
85,800
+72,800
| +560% | +$9.71M |
|
1309
Ventas
VTR
$48.1B
| $10.2M | 0.01% |
159,132
+80,195
| +102% | +$4.68M |
|
1310
CALL
Li Auto
LI
$12B
| $10.2M | 0.01% |
397,800
+49,900
| +14% | +$1.01M |
|
1311
CALL
Whirlpool
WHR
$2.65B
| $10.2M | 0.01% |
95,300
+18,800
| +25% | +$1.89M |
|
1312
NovoCure
NVCR
$2.05B
| $10.2M | 0.01% |
650,314
-48,980
| -7% | -$888K |
|
1313
PUT
Lamb Weston
LW
$7.61B
| $10.2M | 0.01% |
156,800
+140,700
| +874% | +$9.29M |
|
1314
CALL
Gilead Sciences
GILD
$184B
| $10.1M | 0.01% |
+120,600
| New | +$9.2M |
|
|
GPGI
1315
GPGI Inc
GPGI
$3.94B
| $10.1M | 0.01% |
867,205
+656,404
| +311% | +$5.56M |
|
1316
Century Communities
CCS
$2B
| $10.1M | 0.01% |
97,652
-15,792
| -14% | -$1.51M |
|
1317
Gogo Inc
GOGO
$369M
| $10.1M | 0.01% |
1,400,071
-337,414
| -19% | -$2.75M |
|
1318
PUT
Pultegroup
PHM
$24.9B
| $10M | 0.01% |
70,000
| – | – |
|
1319
Unilever
UL
$140B
| $10M | 0.01% |
+137,397
| New | +$9.5M |
|
|
RVNC
1320
DELISTED
Revance Therapeutics, Inc.
RVNC
| $10M | 0.01% |
1,932,205
+1,824,225
| +1,689% | +$9.07M |
|
1321
Canadian Imperial Bank of Commerce
CM
$108B
| $10M | 0.01% |
163,112
+106,312
| +187% | +$5.76M |
|
1322
Pitney Bowes
PBI
$2.34B
| $10M | 0.01% |
1,402,750
-224,884
| -14% | -$1.52M |
|
1323
CALL
Etsy
ETSY
$7.75B
| $9.98M | 0.01% |
179,700
+102,500
| +133% | +$5.82M |
|
1324
StoneCo
STNE
$2.26B
| $9.96M | 0.01% |
884,241
-888,101
| -50% | -$11.3M |
|
|
MPT
1325
CALL
Medical Properties Trust
MPT
$2.45B
| $9.96M | 0.01% |
1,701,800
+1,164,100
| +216% | +$5.74M |
|
Similar funds
David Shaw's Q3 2024 Portfolio in Review
As of Q3 2024, David Shaw held 5,052 positions worth $116B, up 8.9% from $107B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw's Q3 2024 filing shows 599 new, 1,568 increased, 1,742 reduced and 558 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 1,429,800 shares worth $115M. The largest sale was Adobe, an estimated $646M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q3 2024 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 1,429,800 shares worth $115M.
- David Shaw added most to NVIDIA in Q3 2024, an estimated $708M increase.
- David Shaw's biggest Q3 2024 reduction was Adobe, cutting an estimated $646M.
- David Shaw fully exited WestRock Company in Q3 2024, selling an estimated $148M.
- David Shaw's ten largest holdings make up 9.6% of its $116B portfolio in Q3 2024.
- David Shaw opened 599 new positions and closed 558 in Q3 2024.
- David Shaw's portfolio value rose 8.9% quarter-over-quarter to $116B.
Based on D.E. Shaw & Co's 13F filing for Q3 2024, filed 14 Nov 2024.